AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019
Jun 19, 2019
30583_dirs_2019-06-19_d8fc1a12-225f-41de-97a9-76ea3a6fb5a3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-06-17
Reporting Person: LAWLIS V BRYAN (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-17 | Common Stock | M | 3750 | $21.510 | Acquired | 27340 | Direct |
| 2019-06-17 | Common Stock | S | 3750 | $81.080 | Disposed | 23590 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-17 | Stock Option (Right to buy Common Stock) | $21.510 | M | 3750 | Disposed | 2020-05-11 | Common Stock (3750) | Direct |
Footnotes
F1: Trade made pursuant to a 10b5-1 plan executed on May 1, 2019.
F2: Reflects the number of options outstanding after the transactions from the specific stock option grant.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19